New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful push for the Covid-19 vaccine.
Cancer vaccine research at the biotech company Moderna in Cambridge, Mass., which reported in August promising results that a melanoma vaccine increased the time before cancers recurred and increased the time before the cancers spread.
Vaccine safety experts say more research into the side effects would be welcome yet question whether the health secretary’s effort will be grounded in science.
Drawing blood at an H.I.V. clinic in South Africa last year. The research networks’ large footprint has enabled them to develop tools to prevent and treat H.I.V., including in marginalized or rare populations.
N.I.H. is the nation’s largest research agency, which disburses much of its $48 billion annual budget to labs and academic researchers who study cancer, infectious diseases and other health priorities.
Federal officials are drafting an executive order that would place grants under review by an outside panel, the latest effort to redirect billions of dollars in research spending.
Russell Vought, the director of the Office of Management and Budget, speaks during a White House event earlier this year. Mr. Vought’s efforts to impose more outside control over N.I.H. grant approvals have resulted in tension with the N.I.H. director, Dr. Jay Bhattacharya.
As Dr. Anthony Fauci has faced public scrutiny from congressional Republicans, the D.O.J. has pursued a quieter and more expansive effort against a wider circle of researchers.
Under a new partnership, the Defense Department would play a larger role in biodefense and pandemic preparedness. Democrats warned it could allow a Pentagon cash grab.
Login
